Tianlan Li
Qingdao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-world efficacy and safety of the carfilzomib-pomalidomide-dexamethasone regimen in patients with relapsed/refractory multiple myeloma: A multicenter retrospective study.
Journal: Therapeutic advances in hematology
Published: July 08, 2025
Analysis of risk factors for major adverse cardiac events in patients with multiple myeloma.
Journal: Frontiers in cardiovascular medicine
Published: May 30, 2025
Comment to: "Treatment of a STAT5b::RARα positive case of APL in a patient not eligible for intensive chemotherapy".
Journal: Irish journal of medical science
Published: April 12, 2025
Recombinant human thrombopoietin reduces the risk of acute graft-versus-host-disease and its mechanism.
Journal: Transplant immunology
Published: September 23, 2024
Clinical features and treatment of newly diagnosed multiple myeloma with secondary myelofibrosis: a retrospective study.
Journal: Therapeutic advances in hematology
Published: April 22, 2024
A novel study on CXXC5: unraveling its regulatory mechanisms in hematopoietic stem cell biology through proteomics and gene editing.
Journal: Genes & genomics
Published: March 05, 2024
Decitabine: An effective and safe treatment for myelodysplastic syndrome and acute myeloid leukemia.
Decitabine: An effective and safe treatment for myelodysplastic syndrome and acute myeloid leukemia.
Journal: Journal of cancer research and therapeutics
Published: January 16, 2020
3D culture enhances chemoresistance of ALL Jurkat cell line by increasing DDR1 expression.
Journal: Experimental and therapeutic medicine
Published: May 24, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026